{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T17:23:31Z","timestamp":1744997011589},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1038\/sj.bjc.6605516","type":"journal-article","created":{"date-parts":[[2010,1,5]],"date-time":"2010-01-05T21:21:28Z","timestamp":1262726488000},"page":"436-446","source":"Crossref","is-referenced-by-count":7,"title":["EWS-Oct-4B, an alternative EWS-Oct-4 fusion gene, is a potent oncogene linked to human epithelial tumours"],"prefix":"10.1038","volume":"102","author":[{"given":"S","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,1,5]]},"reference":[{"key":"BF6605516_CR1","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/nbt.1503","volume":"26","author":"T Aasen","year":"2008","unstructured":"Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, Vassena R, Bilic J, Pekarik V, Tiscornia G, Edel M, Boue S, Belmonte JC (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26: 1276\u20131284","journal-title":"Nat Biotechnol"},{"key":"BF6605516_CR2","doi-asserted-by":"publisher","first-page":"6321","DOI":"10.1128\/MCB.17.11.6321","volume":"17","author":"DC Ambrosetti","year":"1997","unstructured":"Ambrosetti DC, Basilico C, Dailey L (1997) Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites. Mol Cell Biol 17: 6321\u20136329","journal-title":"Mol Cell Biol"},{"key":"BF6605516_CR3","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1101\/gad.12.13.2073","volume":"12","author":"V Botquin","year":"1998","unstructured":"Botquin V, Hess H, Fuhrmann G, Anastassiadis C, Gross MK, Vriend G, Scholer HR (1998) New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2. Genes Dev 12: 2073\u20132090","journal-title":"Genes Dev"},{"key":"BF6605516_CR4","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/0092-8674(90)90348-I","volume":"60","author":"M Breeuwer","year":"1990","unstructured":"Breeuwer M, Goldfarb DS (1990) Facilitated nuclear transport of histone H1 and other small nucleophilic proteins. Cell 60: 999\u20131008","journal-title":"Cell"},{"key":"BF6605516_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1128\/MCB.17.1.154","volume":"17","author":"A Brehm","year":"1997","unstructured":"Brehm A, Ohbo K, Scholer H (1997) The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain. Mol Cell Biol 17: 154\u2013162","journal-title":"Mol Cell Biol"},{"key":"BF6605516_CR6","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1200\/JCO.1998.16.4.1248","volume":"16","author":"E de Alava","year":"1998","unstructured":"de Alava E, Kawai A, Healey JH, Fligman I, Meyers PA, Huvos AG, Gerald WL, Jhanwar SC, Argani P, Antonescu CR, Pardo-Mindan FJ, Ginsberg J, Womer R, Lawlor ER, Wunder J, Andrulis I, Sorensen PH, Barr FG, Ladanyi M (1998) EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol 16: 1248\u20131255","journal-title":"J Clin Oncol"},{"key":"BF6605516_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/359162a0","volume":"359","author":"O Delattre","year":"1992","unstructured":"Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G, Aurias A, Thomas G (1992) Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359: 162\u2013165","journal-title":"Nature"},{"key":"BF6605516_CR8","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1126\/science.1158799","volume":"321","author":"JT Dimos","year":"2008","unstructured":"Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF, Saphier G, Leibel R, Goland R, Wichterle H, Henderson CE, Eggan K (2008) Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321: 1218\u20131221","journal-title":"Science"},{"key":"BF6605516_CR9","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/0968-0004(91)90184-W","volume":"16","author":"C Dingwall","year":"1991","unstructured":"Dingwall C, Laskey RA (1991) Nuclear targeting sequences \u2013 a consensus? Trends Biochem Sci 16: 478\u2013481","journal-title":"Trends Biochem Sci"},{"key":"BF6605516_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1535-6108(03)00270-8","volume":"4","author":"S Gidekel","year":"2003","unstructured":"Gidekel S, Pizov G, Bergman Y, Pikarsky E (2003) Oct-3\/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 4: 361\u2013370","journal-title":"Cancer Cell"},{"key":"BF6605516_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/00001622-200305000-00010","volume":"15","author":"BA Hellerstedt","year":"2003","unstructured":"Hellerstedt BA, Pienta KJ (2003) Germ cell tumors: review of selected studies from 2002. Curr Opin Oncol 15: 234\u2013238","journal-title":"Curr Opin Oncol"},{"key":"BF6605516_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.cell.2005.02.018","volume":"121","author":"K Hochedlinger","year":"2005","unstructured":"Hochedlinger K, Yamada Y, Beard C, Jaenisch R (2005) Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121: 465\u2013477","journal-title":"Cell"},{"key":"BF6605516_CR13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.stem.2008.08.014","volume":"3","author":"D Hockemeyer","year":"2008","unstructured":"Hockemeyer D, Soldner F, Cook EG, Gao Q, Mitalipova M, Jaenisch R (2008) A drug-inducible system for direct reprogramming of human somatic cells to pluripotency. Cell Stem Cell 3: 346\u2013353","journal-title":"Cell Stem Cell"},{"key":"BF6605516_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/(SICI)1097-0215(19990331)81:1<104::AID-IJC18>3.0.CO;2-Q","volume":"81","author":"T Jin","year":"1999","unstructured":"Jin T, Branch DR, Zhang X, Qi S, Youngson B, Goss PE (1999) Examination of POU homeobox gene expression in human breast cancer cells. Int J Cancer 81: 104\u2013112","journal-title":"Int J Cancer"},{"key":"BF6605516_CR15","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1038\/sj.onc.1201716","volume":"16","author":"J Kim","year":"1998","unstructured":"Kim J, Lee K, Pelletier J (1998a) The desmoplastic small round cell tumor t(11;22) translocation produces EWS\/WT1 isoforms with differing oncogenic properties. Oncogene 16: 1973\u20131979","journal-title":"Oncogene"},{"key":"BF6605516_CR16","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/sj.onc.1201616","volume":"16","author":"J Kim","year":"1998","unstructured":"Kim J, Lee K, Pelletier J (1998b) The DNA binding domains of the WT1 tumor suppressor gene product and chimeric EWS\/WT1 oncoprotein are functionally distinct. Oncogene 16: 1021\u20131030","journal-title":"Oncogene"},{"key":"BF6605516_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1152\/physiolgenomics.1999.1.3.127","volume":"1","author":"J Kim","year":"1999","unstructured":"Kim J, Pelletier J (1999) Molecular genetics of chromosome translocations involving EWS and related family members. Physiol Genomics 1: 127\u2013138","journal-title":"Physiol Genomics"},{"key":"BF6605516_CR18","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1002\/ijc.23379","volume":"122","author":"S Kim","year":"2008","unstructured":"Kim S, Lee HJ, Jun HJ, Kim J (2008) The hTAF II 68-TEC fusion protein functions as a strong transcriptional activator. Int J Cancer 122: 2446\u20132453","journal-title":"Int J Cancer"},{"key":"BF6605516_CR19","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1002\/ijc.24228","volume":"124","author":"S Kim","year":"2009","unstructured":"Kim S, Lee J, Kim JY, Lim B, Shin EK, Han YM, Kim SS, Song JH, Kim J (2009) Mutation in the DNA-binding domain of the EWS-Oct-4 oncogene results in dominant negative activity that interferes with EWS-Oct-4-mediated transactivation. Int J Cancer 124: 2312\u20132322","journal-title":"Int J Cancer"},{"key":"BF6605516_CR20","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1128\/MCB.25.6.2475-2485.2005","volume":"25","author":"T Kuroda","year":"2005","unstructured":"Kuroda T, Tada M, Kubota H, Kimura H, Hatano SY, Suemori H, Nakatsuji N, Tada T (2005) Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol Cell Biol 25: 2475\u20132485","journal-title":"Mol Cell Biol"},{"key":"BF6605516_CR21","doi-asserted-by":"publisher","first-page":"33554","DOI":"10.1074\/jbc.M603937200","volume":"281","author":"J Lee","year":"2006","unstructured":"Lee J, Kim HK, Rho JY, Han YM, Kim J (2006) The human OCT-4 isoforms differ in their ability to confer self-renewal. J Biol Chem 281: 33554\u201333565","journal-title":"J Biol Chem"},{"key":"BF6605516_CR22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1042\/BJ20070243","volume":"406","author":"J Lee","year":"2007","unstructured":"Lee J, Kim JY, Kang IY, Kim HK, Han YM, Kim J (2007) The EWS-Oct-4 fusion gene encodes a transforming gene. Biochem J 406: 519\u2013526","journal-title":"Biochem J"},{"key":"BF6605516_CR23","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1634\/stemcells.2004-0375","volume":"23","author":"J Lee","year":"2005","unstructured":"Lee J, Rhee BK, Bae GY, Han YM, Kim J (2005) Stimulation of Oct-4 activity by Ewing's sarcoma protein. Stem Cells 23: 738\u2013751","journal-title":"Stem Cells"},{"key":"BF6605516_CR24","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/cr.2007.22","volume":"17","author":"KA Lee","year":"2007","unstructured":"Lee KA (2007) Ewings family oncoproteins: drunk, disorderly and in search of partners. Cell Res 17: 286\u2013288","journal-title":"Cell Res"},{"key":"BF6605516_CR25","first-page":"1428","volume":"59","author":"PP Lin","year":"1999","unstructured":"Lin PP, Brody RI, Hamelin AC, Bradner JE, Healey JH, Ladanyi M (1999) Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma. Cancer Res 59: 1428\u20131432","journal-title":"Cancer Res"},{"key":"BF6605516_CR26","first-page":"2244","volume":"63","author":"LH Looijenga","year":"2003","unstructured":"Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, van Zoelen EJ, Weber RF, Wolffenbuttel KP, van Dekken H, Honecker F, Bokemeyer C, Perlman EJ, Schneider DT, Kononen J, Sauter G, Oosterhuis JW (2003) POU5F1 (OCT3\/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 63: 2244\u20132250","journal-title":"Cancer Res"},{"key":"BF6605516_CR27","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1073\/pnas.0711983105","volume":"105","author":"WE Lowry","year":"2008","unstructured":"Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, Sridharan R, Clark AT, Plath K (2008) Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci USA 105: 2883\u20132888","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6605516_CR28","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.stem.2008.08.003","volume":"3","author":"N Maherali","year":"2008","unstructured":"Maherali N, Ahfeldt T, Rigamonti A, Utikal J, Cowan C, Hochedlinger K (2008) A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 3: 340\u2013345","journal-title":"Cell Stem Cell"},{"key":"BF6605516_CR29","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1016\/j.yexcr.2009.06.016","volume":"315","author":"H Makino","year":"2009","unstructured":"Makino H, Toyoda M, Matsumoto K, Saito H, Nishino K, Fukawatase Y, Machida M, Akutsu H, Uyama T, Miyagawa Y, Okita H, Kiyokawa N, Fujino T, Ishikawa Y, Nakamura T, Umezawa A (2009) Mesenchymal to embryonic incomplete transition of human cells by chimeric OCT4\/3 (POU5F1) with physiological co-activator EWS. Exp Cell Res 315: 2727\u20132740","journal-title":"Exp Cell Res"},{"key":"BF6605516_CR30","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/path.2327","volume":"215","author":"E Moller","year":"2008","unstructured":"Moller E, Stenman G, Mandahl N, Hamberg H, Molne L, van den Oord JJ, Brosjo O, Mertens F, Panagopoulos I (2008) POU5F1, encoding a key regulator of stem cell pluripotency, is fused to EWSR1 in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glands. J Pathol 215: 78\u201386","journal-title":"J Pathol"},{"key":"BF6605516_CR31","doi-asserted-by":"publisher","first-page":"8085","DOI":"10.1038\/sj.onc.1205088","volume":"20","author":"M Monk","year":"2001","unstructured":"Monk M, Holding C (2001) Human embryonic genes re-expressed in cancer cells. Oncogene 20: 8085\u20138091","journal-title":"Oncogene"},{"key":"BF6605516_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nbt1374","volume":"26","author":"M Nakagawa","year":"2008","unstructured":"Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, Yamanaka S (2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26: 101\u2013106","journal-title":"Nat Biotechnol"},{"key":"BF6605516_CR33","doi-asserted-by":"publisher","first-page":"5453","DOI":"10.1128\/MCB.19.8.5453","volume":"19","author":"M Nishimoto","year":"1999","unstructured":"Nishimoto M, Fukushima A, Okuda A, Muramatsu M (1999) The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3\/4 and Sox-2. Mol Cell Biol 19: 5453\u20135465","journal-title":"Mol Cell Biol"},{"key":"BF6605516_CR34","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/74199","volume":"24","author":"H Niwa","year":"2000","unstructured":"Niwa H, Miyazaki J, Smith AG (2000) Quantitative expression of Oct-3\/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24: 372\u2013376","journal-title":"Nat Genet"},{"key":"BF6605516_CR35","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature05934","volume":"448","author":"K Okita","year":"2007","unstructured":"Okita K, Ichisaka T, Yamanaka S (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448: 313\u2013317","journal-title":"Nature"},{"key":"BF6605516_CR36","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/00001622-199905000-00017","volume":"11","author":"RT Oliver","year":"1999","unstructured":"Oliver RT (1999) Germ cell cancer. Curr Opin Oncol 11: 236\u2013241","journal-title":"Curr Opin Oncol"},{"key":"BF6605516_CR37","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/molehr\/4.11.1021","volume":"4","author":"CE Ovitt","year":"1998","unstructured":"Ovitt CE, Scholer HR (1998) The molecular biology of Oct-4 in the early mouse embryo. Mol Hum Reprod 4: 1021\u20131031","journal-title":"Mol Hum Reprod"},{"key":"BF6605516_CR38","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/path.1064","volume":"196","author":"C Palumbo","year":"2002","unstructured":"Palumbo C, van Roozendaal K, Gillis AJ, van Gurp RH, de Munnik H, Oosterhuis JW, van Zoelen EJ, Looijenga LH (2002) Expression of the PDGF alpha-receptor 1.5\u2009kb transcript, OCT-4, and c-KIT in human normal and malignant tissues. Implications for the early diagnosis of testicular germ cell tumours and for our understanding of regulatory mechanisms. J Pathol 196: 467\u2013477","journal-title":"J Pathol"},{"key":"BF6605516_CR39","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","volume":"134","author":"IH Park","year":"2008","unstructured":"Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ (2008a) Disease-specific induced pluripotent stem cells. Cell 134: 877\u2013886","journal-title":"Cell"},{"key":"BF6605516_CR40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nature06534","volume":"451","author":"IH Park","year":"2008","unstructured":"Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ (2008b) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451: 141\u2013146","journal-title":"Nature"},{"key":"BF6605516_CR41","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1634\/stemcells.19-4-271","volume":"19","author":"M Pesce","year":"2001","unstructured":"Pesce M, Scholer HR (2001) Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 19: 271\u2013278","journal-title":"Stem Cells"},{"key":"BF6605516_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/(SICI)1096-9896(199901)187:1<39::AID-PATH235>3.0.CO;2-Q","volume":"187","author":"TH Rabbitts","year":"1999","unstructured":"Rabbitts TH (1999) Perspective: chromosomal translocations can affect genes controlling gene expression and differentiation \u2013 why are these functions targeted? J Pathol 187: 39\u201342","journal-title":"J Pathol"},{"key":"BF6605516_CR43","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nm0403-383","volume":"9","author":"TH Rabbitts","year":"2003","unstructured":"Rabbitts TH, Stocks MR (2003) Chromosomal translocation products engender new intracellular therapeutic technologies. Nat Med 9: 383\u2013386","journal-title":"Nat Med"},{"key":"BF6605516_CR44","doi-asserted-by":"publisher","first-page":"24731","DOI":"10.1074\/jbc.M502573200","volume":"280","author":"DJ Rodda","year":"2005","unstructured":"Rodda DJ, Chew JL, Lim LH, Loh YH, Wang B, Ng HH, Robson P (2005) Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem 280: 24731\u201324737","journal-title":"J Biol Chem"},{"key":"BF6605516_CR45","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.cell.2009.02.013","volume":"136","author":"F Soldner","year":"2009","unstructured":"Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A, Cooper O, Mitalipova M, Isacson O, Jaenisch R (2009) Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136: 964\u2013977","journal-title":"Cell"},{"key":"BF6605516_CR46","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861\u2013872","journal-title":"Cell"},{"key":"BF6605516_CR47","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663\u2013676","journal-title":"Cell"},{"key":"BF6605516_CR48","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1093\/nar\/20.17.4613","volume":"20","author":"J Takeda","year":"1992","unstructured":"Takeda J, Seino S, Bell GI (1992) Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucleic Acids Res 20: 4613\u20134620","journal-title":"Nucleic Acids Res"},{"key":"BF6605516_CR49","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1042\/bj20030579","volume":"375","author":"P Wang","year":"2003","unstructured":"Wang P, Branch DR, Bali M, Schultz GA, Goss PE, Jin T (2003) The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells. Biochem J 375: 199\u2013205","journal-title":"Biochem J"},{"key":"BF6605516_CR50","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.stem.2007.12.001","volume":"2","author":"M Wernig","year":"2008","unstructured":"Wernig M, Meissner A, Cassady JP, Jaenisch R (2008) c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2: 10\u201312","journal-title":"Cell Stem Cell"},{"key":"BF6605516_CR51","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature05944","volume":"448","author":"M Wernig","year":"2007","unstructured":"Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R (2007) In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448: 318\u2013324","journal-title":"Nature"},{"key":"BF6605516_CR52","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/gcc.20171","volume":"43","author":"S Yamaguchi","year":"2005","unstructured":"Yamaguchi S, Yamazaki Y, Ishikawa Y, Kawaguchi N, Mukai H, Nakamura T (2005) EWSR1 is fused to POU5F1 in a bone tumor with translocation t(6;22)(p21;q12). Genes Chromosomes Cancer 43: 217\u2013222","journal-title":"Genes Chromosomes Cancer"},{"key":"BF6605516_CR53","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1200\/JCO.1996.14.4.1245","volume":"14","author":"A Zoubek","year":"1996","unstructured":"Zoubek A, Dockhorn-Dworniczak B, Delattre O, Christiansen H, Niggli F, Gatterer-Menz I, Smith TL, Jurgens H, Gadner H, Kovar H (1996) Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol 14: 1245\u20131251","journal-title":"J Clin Oncol"},{"key":"BF6605516_CR54","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.1002\/j.1460-2075.1993.tb06137.x","volume":"12","author":"J Zucman","year":"1993","unstructured":"Zucman J, Melot T, Desmaze C, Ghysdael J, Plougastel B, Peter M, Zucker JM, Triche TJ, Sheer D, Turc-Carel C, Ambros P, Combaret V, Lenoir G, Aurias A, Thomas G, Delattre O (1993) Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J 12: 4481\u20134487","journal-title":"EMBO J"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6605516.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605516","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605516.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:43:39Z","timestamp":1684413819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6605516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["BF6605516"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6605516","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}